Theo-24 - 50474-200-01 - (theophylline anhydrous)

Alphabetical Index


Drug Information of Theo-24

Product NDC: 50474-200
Proprietary Name: Theo-24
Non Proprietary Name: theophylline anhydrous
Active Ingredient(s): 200    mg/1 & nbsp;   theophylline anhydrous
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Theo-24

Product NDC: 50474-200
Labeler Name: UCB, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA087943
Marketing Category: ANDA
Start Marketing Date: 19980120

Package Information of Theo-24

Package NDC: 50474-200-01
Package Description: 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50474-200-01)

NDC Information of Theo-24

NDC Code 50474-200-01
Proprietary Name Theo-24
Package Description 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50474-200-01)
Product NDC 50474-200
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name theophylline anhydrous
Dosage Form Name CAPSULE, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 19980120
Marketing Category Name ANDA
Labeler Name UCB, Inc.
Substance Name THEOPHYLLINE ANHYDROUS
Strength Number 200
Strength Unit mg/1
Pharmaceutical Classes Methylxanthine [EPC],Xanthines [Chemical/Ingredient]

Complete Information of Theo-24


General Information